Product Details:
| Strength | 150 mg/vial |
| Packaging Type | Vial |
| Brand | Aprecap iv injection |
| Manufactured By | Glenmark |
| Prescription/Non Prescription | Prescription |
| Country of Origin | Made in India |
Aprecap IV (150mg injection) is used to prevent nausea and vomiting caused by chemotherapy in adults and children aged 6 months and older. It is also used in adults to prevent nausea and vomiting after surgery. Aprecap works by blocking certain chemicals in the brain that can trigger these symptoms.
Key uses of Aprecap IV
Chemotherapy-induced nausea and vomiting (CINV): It is used to prevent both immediate and delayed nausea and vomiting that can be a distressing side effect of anti-cancer treatments like chemotherapy and radiation therapy. It is often used as part of a combination therapy.
Postoperative nausea and vomiting (PONV): It is used to prevent nausea and vomiting after surgery in adults.
How it works
Aprecap contains fosaprepitant, which belongs to a group of antiemetic drugs.
It works by blocking the action of a substance in the brain called neurokinin-1 (NK1).
This helps prevent the signals that cause nausea and vomiting from reaching the brain.
Important considerations
Aprecap IV is a prescription medication and must be administered by a healthcare professional.
It may be used in combination with other medications for effective management.
Inform your doctor if you have liver problems before receiving this medication.